Inflammation associated cancers and potential therapeutics

Simple item page
dc.contributor.authorRose, Aaron Hugh
dc.date.accessioned2015-10-02T20:36:31Z
dc.date.available2015-10-02T20:36:31Z
dc.date.issued2014-05
dc.descriptionPh.D. University of Hawaii at Manoa 2014.
dc.descriptionIncludes bibliographical references.
dc.description.abstractInflammation is a major contributing factor in approximately 20% of cancers, and two types of cancer in which inflammation plays a particularly crucial role are mesothelioma and colorectal carcinoma. Both mesothelioma and colon cancer are induced by the production of TNFα. Moreover, these two cancers are both largely driven by inflammation resulting from macrophage activation. Mesothelioma arises from the transformation of mesothelial cells induced by inflammatory mediators secreted during the aberrant activation of macrophages exposed to asbestos particles. Similarly, colorectal cancer involves the transformation of epithelial cells lining the intestine and tumor progression may be driven by inflammation resulting from macrophage activation by commensal bacteria of the gut. The work described in this thesis focuses on mouse models of mesothelioma and colorectal cancer in an attempt to dissect molecular mechanisms that regulate tumor progression and identify possible intervention strategies for each type of cancer. In the case of mesothelioma we investigated intervention with increasing dietary concentrations of selenium in order to see if the increase in antioxidant enzyme activity could aid the anti-cancer immunity. Independent of any effects on anti-cancer immunity, we found that increasing dietary selenium altered the redox status of certain mesothelioma tumors in a manner that increased tumor progression. Select mesothelioma cell lines were identified that were capable of using higher levels of bioavailable selenium to grow more rapidly and this led to increased in vivo tumor progression. In our second project involving colorectal cancer, we focused on calpain enzymes and their endogenous inhibitor, calpastatin. Our earlier work showed that calpastatin is dynamically regulated in the inflammatory activation of macrophages but not in other immune cell-types and that macrophages express calpain-2. This led us to our hypothesis that using a synthetic inhibitor to decrease calpain-2 activity beyond the normal regulation of calpain-2 activity via the endogenous inhibitor calpastatin will protect mice from colitis and inflammation driven colorectal cancer. Calpain-2 inhibitor treatment showed a significant protective effect against colitis and colorectal cancer in the mouse model of colitis and CAC.
dc.identifier.urihttp://hdl.handle.net/10125/100474
dc.language.isoeng
dc.publisher[Honolulu] : [University of Hawaii at Manoa], [May 2014]
dc.relationTheses for the degree of Doctor of Philosophy (University of Hawaii at Manoa). Cell and Molecular Biology.
dc.rightsAll UHM dissertations and theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission from the copyright owner.
dc.subjectInflammation
dc.subjectmesothelioma
dc.subjectcolorectal carcinoma
dc.titleInflammation associated cancers and potential therapeutics
dc.typeThesis
dc.type.dcmiText

Files

Original bundle
Now showing 1 - 2 of 2
No Thumbnail Available
Name:
Rose_Aaron_r.pdf
Size:
2.93 MB
Format:
Adobe Portable Document Format
Description:
Version for non-UH users. Copying/Printing is not permitted
Download
No Thumbnail Available
Name:
Rose_Aaron_uh.pdf
Size:
2.97 MB
Format:
Adobe Portable Document Format
Description:
Version for UH users
Download

Collections

Ph.D. - Cell and Molecular Biology